Latest current assets for CNTB: $51M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Connect Biopharma Holdings (CNTB) currently reports a current assets of $51M as of December 2025. That compares with $97M in the prior-year period — down 47.5% year over year. Use the charts on this page to explore Connect Biopharma Holdings's current assets history and peer comparisons.
Connect Biopharma Holdings's current assets decreased from $97M to $51M — a 47.5% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Connect Biopharma Holdings reported $51M in current assets as of December 2025. That compares with $97M in the prior-year period — down 47.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $51M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Connect Biopharma Holdings, and consider following CNTB for alerts when major investors trade the stock.
Connect Biopharma Holdings is classified in the Healthcare sector. On current assets, it currently shows $51M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CNTB with unrelated industries.